GlassScriptPhysician profile
Katie Joy Barger
NPI 1811222367
$2,155.20
in general payments reported to CMS, 2019-2025
28 companies · $422 in 2025
The $422 reported for 2025 was more than what a typical Pediatric Endocrinology provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $790 · 2020: $45.15 · 2021: $210 · 2022: $233 · 2023: $319 · 2024: $136 · 2025: $422.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $877.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $876.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $272.01 | 2019-2025 | Lupron Depot |
| Novo Nordisk INC | $264.69 | 2019-2024 | Novoseven, Novoeight, Sogroya |
| Pfizer INC. | $215.33 | 2021-2025 | |
| Medtronic, INC. | $177.11 | 2021-2024 | Inpen Smart Insulin Delivery System, Minimed 780g |
| Lilly USA, LLC | $148.90 | 2019 | |
| Amgen INC. | $108.24 | 2019 | |
| Insulet Corporation | $98.11 | 2019-2023 | Omnipod |
| Sequel Med Tech, LLC | $95.68 | 2025 | Twiist |
| Beta Bionics, INC. | $88.83 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Tandem Diabetes Care, INC. | $76.65 | 2023-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Dexcom, INC. | $71.16 | 2023-2025 | Dexcom G6 Transmitter, Dexcom G7 Gss (161) |
| Intuity Medical INC | $58.11 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Sanofi-Aventis U.S. LLC | $55.90 | 2019-2023 | |
| Xeris Pharmaceuticals, INC. | $54.28 | 2021-2025 | Gvoke Hypopen |
| Corcept Therapeutics | $53.97 | 2019-2020 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Minimed, INC. | $41.19 | 2019 | |
| Biomarin Pharmaceutical INC. | $39.44 | 2021-2022 | |
| Ascendis Pharma Endocrinology INC | $35.77 | 2022-2024 | |
| Tolmar Pharmaceuticals, INC. | $35.46 | 2021-2022 | |
| Companion Medical, INC. | $30.14 | 2019-2020 | |
| Eton Pharmaceuticals, INC. | $23.78 | 2025 | Increlex, Alkindi, Khindivi |
| Abbott Laboratories | $23.40 | 2021 | |
| Rhythm Pharmaceuticals, INC. | $19.23 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $14.80 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $14.80 | 2019 | |
| Arbor Pharmaceuticals, INC. | $14.05 | 2019 | |
| Ibsa Pharma INC. | $12.22 | 2019 | |
| Alexion Pharmaceuticals, INC. | $11.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katie Barger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.